P V Sorokin

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Terapevticheskii arkhiv

This page only lists publications with an associated author ORCID identifier.

Publications

A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, O P Kovtun, P L Kuznetsov, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19]. Terapevticheskii arkhiv 96 (5) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19]. Terapevticheskii arkhiv 96 (3) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, O P Kovtun, P L Kuznetsov, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19]. Terapevticheskii arkhiv 96 (5) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, O P Kovtun, P L Kuznetsov, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19]. Terapevticheskii arkhiv 96 (5) (2024)
A U Sabitov, Dmitriy A Lioznov, K V Zhdanov, E P Tihonova, E V Esaulenko, P V Sorokin
[Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19]. Terapevticheskii arkhiv 96 (3) (2024)
A U Sabitov, O P Kovtun, E V Esaulenko, P V Sorokin
[A new approach to etiotropic therapy ARVI in children]. Terapevticheskii arkhiv 94 (11) (2022)
A U Sabitov, O P Kovtun, E V Esaulenko, P V Sorokin
[A new approach to etiotropic therapy ARVI in children]. Terapevticheskii arkhiv 94 (11) (2022)
A U Sabitov, O P Kovtun, E V Esaulenko, P V Sorokin
[A new approach to etiotropic therapy ARVI in children]. Terapevticheskii arkhiv 94 (11) (2022)
A U Sabitov, P V Sorokin, S Y Dashutina
[Experience of the preventive use of the drug Riamilovir in the foci of coronavirus infection (COVID-19)]. Terapevticheskii arkhiv 93 (4) (2021)
K V Kasyanenko, K V Kozlov, O V Maltsev, I I Lapikov, V V Gordienko, V V Sharabkhanov, P V Sorokin, K V Zhdanov
[Evaluation of the effectiveness of Riamilovir in the complex therapy of patients with COVID-19]. Terapevticheskii arkhiv 93 (3) (2021)
Dmitriy A Lioznov, I I Tokin, T G Zubkova, P V Sorokin
[The practice of using a domestic antiviral drug in the etiotropic therapy of acute respiratory viral infection]. Terapevticheskii arkhiv 92 (12) (2020)